2. Signaling Pathways
  3. Metabolic Enzyme/Protease
  4. Drug Metabolite

Drug Metabolite

Drug Metabolite

Related Products

PDF 3.95 MB

Drug metabolite results when a drug is metabolized into a modified form which continues to produce effects. Drug metabolism redox reactions such as heteroatom dealkylations, hydroxylations, heteroatom oxygenations, reductions, and dehydrogenations can yield active metabolites, and in rare cases even conjugation reactions can yield an active metabolite.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-125691
    LY-338979
    		99.67%
    LY-338979 (Pemetrexed 6-oxo diacid impurity) is a metabolite of LY231514 (Pemetrexed; HY-10820).
    LY-338979
  • HY-135377
    Atorvastatin 3-Deoxyhept-2E-Enoic Acid
    		≥98.0%
    Atorvastatin 3-Deoxyhept-2E-Enoic Acid ((2E)-2,3-Dehydroxy Atorvastatin) is an impurity of Atorvastatin. Atorvastatin is an orally active HMG-CoA reductase inhibitor and has the ability to effectively decrease blood lipids.
    Atorvastatin 3-Deoxyhept-2E-Enoic Acid
  • HY-137912
    trans-Resveratrol-3-O-β-D-Glucuronide
    trans-Resveratrol-3-O-β-D-Glucuronide is an active metabolite of trans-resveratrol. trans-Resveratrol-3-O-β-D-Glucuronide reduces the proliferation of several intestinal cancer cell line. trans-Resveratrol-3-O-β-D-Glucuronide increases pyruvate production in livers.
    trans-Resveratrol-3-O-β-D-Glucuronide
  • HY-138813
    N-Desethyl Sunitinib hydrochloride
    		99.14%
    N-Desethyl Sunitinib (SU-12662) (hydrochloride) is a metabolite of sunitinib. Sunitinib is a potent, ATP-competitive VEGFR, PDGFRβ and KIT inhibitor with Ki values of 2, 9, 17, 8 and 4 nM for VEGFR -1, -2, -3, PDGFRβ and KIT, respectively.
    N-Desethyl Sunitinib hydrochloride
  • HY-133771AS
    Nordoxepin-d3 hydrochloride
    		99.92%
    Nordoxepin-d3 (hydrochloride) is the deuterium labeled Nordoxepin hydrochloride. Nordoxepin hydrochloride is an active metabolite of Doxepin hydrochloride (HY-B0725), which is an orally active tricyclic antidepressant.
    Nordoxepin-d<sub>3</sub> hydrochloride
  • HY-N11424
    Bilirubin diglucuronide
    Bilirubin diglucuronide is the metabolite of Bilirubin (HY-N0323). Bilirubin diglucuronide inhibits MRP1/2 mediated ATP-dependent transport of leukotriene C4 (LTC4) in membrane vesicles.
    Bilirubin diglucuronide
  • HY-116831
    4′-Dihydrophaseic acid
    		98.70%
    4′-Dihydrophaseic acid is an abscisic-acid metabolite.
    4′-Dihydrophaseic acid
  • HY-137316
    Phosphoramide mustard
    Phosphoramide mustard is a biologically active metabolite of Cyclophosphamide (HY-17420), with anticancer activitiy. Phosphoramide mustard induces DNA damage.
    Phosphoramide mustard
  • HY-W011245
    Ranitidine S-oxide
    		99.03%
    Ranitidine S-oxide is the metabolite of Ranitidine (HY-B0693). Ranitidine is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion.
    Ranitidine S-oxide
  • HY-12771
    O-desmethyl Mebeverine acid
    		≥99.0%
    O-desmethyl Mebeverine acid is a metabolite of Mebeverine, which is a musculotropic antispasmodic drug.
    O-desmethyl Mebeverine acid
  • HY-12784
    Cycloguanil
    Cycloguanil, the active metabolite of Proguanil, acts on malaria schizonts in erythrocytes and hepatocytes.
    Cycloguanil
  • HY-133787
    Levofloxacin N-oxide
    		98.28%
    Levofloxacin N-oxide is a minor metabolite of Levofloxacin (HY-B0330). Levofloxacin N-oxide does not exhibit significantly genotoxic risks. Levofloxacin is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria.
    Levofloxacin N-oxide
  • HY-W014225S
    3-Phenoxybenzoic acid-13C6
    		99.29%
    3-Phenoxybenzoic acid-13C6 is the 13C6 labeled 3-Phenoxybenzoic acid. 3-Phenoxybenzoic acid is the metabolite of pyrethroid insecticides. 3-Phenoxybenzoic acid induces immunotoxicity and oxidative stress, and inhibits the phagocytic ability of macrophages.
    3-Phenoxybenzoic acid-<sup>13</sup>C<sub>6</sub>
  • HY-100638
    RPR132595A
    RPR132595A (NPC) is an active metabolite of CPT-11, which is generated by cytochrome P-450 3A4 (CYP3A4) and finally excreted through urine.
    RPR132595A
  • HY-133794
    Dasatinib N-oxide
    		99.24%
    Dasatinib N-oxide is a minor metabolite of Dasatinib. Dasatinib is a potent and orally active dual Src/Bcr-Abl inhibitor.
    Dasatinib N-oxide
  • HY-131280
    Devaleryl Valsartan Impurity
    		99.99%
    Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan.
    Devaleryl Valsartan Impurity
  • HY-131579
    Deschloro Cetirizine dihydrochloride
    		99.44%
    Deschloro Cetirizine Dihydrochloride is a Cetirizine impurity. Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist.
    Deschloro Cetirizine dihydrochloride
  • HY-W424779
    5-Carboxy-2′-deoxyuridine
    		98.98%
    5-Carboxy-2′-deoxyuridine is a metabolite of Trifluridine. 5-Carboxy-2′-deoxyuridine is a methyl oxidation product of Thymidine that can be formed by menadione-mediated photosensitization of Thymidine.
    5-Carboxy-2′-deoxyuridine
  • HY-113376
    Etiocholanolone glucuronide
    		≥98.0%
    Etiocholanolone glucuronide (Etio-G) is the metabolite of Etiocholanolone (HY-113320) that is generated in the liver by UDP glucuonyltransferase. Etiocholanolone glucuronide is promising for research of metabolic-related diseases.
    Etiocholanolone glucuronide
  • HY-N4173
    8-Oxoepiberberine
    		99.72%
    8-Oxoepiberberine is an alkaloid metabolite in the plasma after oral administration of Zuojin formula, a traditional chinese medicine used to treat gastrointestinal disease.
    8-Oxoepiberberine
Cat. No. Product Name / Synonyms Application Reactivity